Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FibroGen, a biotechnology-based drug discovery company, has appointed Toshinari Tamura to its board of directors.
Subscribe to our email newsletter
Dr Tamura has recently retired as representative director, executive vice president and chief science officer of Astellas Pharma.
Dr Tamura has received a PhD degree from the University of Tokyo, Graduate School of Pharmaceutical Sciences.
Thomas Neff, president and CEO of FibroGen, said: “We are honored that Dr Tamura has agreed to join our board of directors. We look forward to working with this experienced pharmaceutical executive who has extensive knowledge of R&D, regulatory and manufacturing matters as we advance all aspects of our business.”